Correlation Between Ascletis Pharma and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ascletis Pharma and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascletis Pharma and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ascletis Pharma and Larimar Therapeutics, you can compare the effects of market volatilities on Ascletis Pharma and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascletis Pharma with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascletis Pharma and Larimar Therapeutics.
Diversification Opportunities for Ascletis Pharma and Larimar Therapeutics
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Ascletis and Larimar is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Ascletis Pharma and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Ascletis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascletis Pharma are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Ascletis Pharma i.e., Ascletis Pharma and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Ascletis Pharma and Larimar Therapeutics
Assuming the 90 days horizon Ascletis Pharma is expected to generate 0.59 times more return on investment than Larimar Therapeutics. However, Ascletis Pharma is 1.71 times less risky than Larimar Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.3 per unit of risk. If you would invest 21.00 in Ascletis Pharma on September 13, 2024 and sell it today you would lose (3.00) from holding Ascletis Pharma or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ascletis Pharma vs. Larimar Therapeutics
Performance |
| Timeline |
| Ascletis Pharma |
| Larimar Therapeutics |
Ascletis Pharma and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ascletis Pharma and Larimar Therapeutics
The main advantage of trading using opposite Ascletis Pharma and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascletis Pharma position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Ascletis Pharma vs. Sino Biopharmaceutical Ltd | Ascletis Pharma vs. Defence Therapeutics | Ascletis Pharma vs. Aileron Therapeutics | Ascletis Pharma vs. Enlivex Therapeutics |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |